Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians

Indian Journal of Medical Research

Volumn 135, Issue 4, 2012, Pages 506-512

  Gupta, Santosh Kumar ^a,c   Kotwal, Jyoti ^a   Kotwal, Atul ^a   Dhall, Anil ^b   Garg, Salil ^b  

^a ARMED FORCES MEDICAL COLLEGE   (India)

^b ARMY HOSPITAL RESEARCH AND REFERRAL   (India)

^c Besides SL Sharma Open University   (India)

Author keywords

Cad; Case control; Gene polymorphism; Homocysteine; MTHFR; Risk factors

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CHOLESTEROL; CYANOCOBALAMIN; EDETIC ACID; FOLIC ACID; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET RESTRICTION; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ANALYSIS; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; INDIAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SMOKING; VITAMIN SUPPLEMENTATION;

ADULT; CHOLESTEROL; CORONARY ARTERY DISEASE; FEMALE; FOLIC ACID; GENETIC ASSOCIATION STUDIES; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INDIA; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; TRIGLYCERIDES; VITAMIN B 12;

EID: 84861925980     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 1999; 81: 165-76.
2. Alfthan G, Pekkanan J, Jauhiainen M, Pitkäniemi J, Karvonem M, Tuomilehto J. Relation of serum homocysteine and lipoprotein (a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994; 106: 9-19.
3. Faraci FM. Hyper homocysteinemia: A million ways to lose control. Arterioscler Thromb Basic Biol 2003; 23: 371-373.
4. Wald DS, Low M, Marris JK. Homocysteine and cardiovascular disease: evidence of causality from meta-analysis. BMJ 2002; 325: 1202-1206.
5. Schnyder G, Roff M, Pin R, Flammer Y, Lange H, Eberli FR, et al. Decrease rate of Coronary re-stenosis after lowering plasma homocysteine levels. N Engl J Med 2001; 345: 1593-1600.
6. Lewis SJ, Shah E, Smith GD. Meta-analysis of MTHFR 677 C→T polymorphism and coronary heart disease. Does totality of evidence support casual role for homocysteine and preventive potential of folate. BMJ 2005; 331: 1053-1070.
7. Clarke R, Bennett DA, Parish S, Verhoef P, Dötsch-Klerk M, et al. Homocysteine and coronary heart disease: Meta-analysis of MTHFR case-control studies, avoiding publication bias. PLoS Med 2012; 9 (2): e1001177.
8. Fletcher O, Kessling AM. MTHFR association with arteriosclerotic vascular disease? Hum Genet 1999; 103: 11-21.
9. Sastry BKS, Nair KG, Nair SR, Ashavaid TF, Dalal JJ, Eghilm FF. Methylene tetra hydrofolatate reductase gene polymorphism and hyperhomocysteinemia as risk factors for coronary heart disease in Indian population. J Assoc Physicians India 2002; 24: 509-515.
10. Deepa R, Velmurugan K, Saravanan G, Karkuzhali K, Dwarkanath V, Mohan V, et al. Absence of association between serum homocysteine levels and coronary artery disease in South Indian males. Indian Heart J 2001; 53: 44-47.
11. Gheye S, Lakshmi AV, Krishna TP, Krishnaswamy K. Fibrinogen and homocysteine levels in coronary heart disease. Indian Heart J 1999; 51: 499-502.
12. Chako KA. Plasma homocysteine levels in patients with coronary heart disease. Indian Heart J 1998; 50: 295-299.
13. Chambers JL, Obeid OA, Refsum H, Ueland P, Hackell D, Hooper J, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK, Indian Asians and Europeans. Lancet 2000; 355: 523-527.
14. Puri A, Gupta DK, Diwedi RN, Bhardwaj RR, Narayan VS, Singh S. Homocysteine and lipid levels in young patients with coronary artery disease. J Assoc Physicians India 2003; 51: 681-685.
15. Khare A, Ghosh K, Shetty S, Kulkarni B, Mohanty D. Combination of Thrombophilia markers in acute myocardial infarction. Indian J Med Sci 2004; 58: 381-388.
16. Nair KG, Nair SR, Ashavaid TF, Dalai JS, Eghlin FF. MTHFR gene mutation and hyperhomocysteinemia as risk factors in coronary heart disease in Indian population. J Assoc Physicians India 2002; 50: 9-15.
17. Nath I, Reddy KS, Dinshaw KA, Bhisey AN, Krishnaswami K, Bhan MK, et al. Country profle: India. Lancet 1998; 351: 1265-1275.
18. Refsum H, Yajnik CS, Gadkari M, Schneede J, Vollset stein E, Orning L, et al. Homocysteine and elevated methylmalonic acid indicate a high prevalence of cobalamin defciency in Asian Indian. Am J Clin Nutr 2001; 74: 233-241.
19. Micheal S, Qamar R, Akhtar F, Khan MI, Khan WA, Ahmed A. MTHFR gene C677T and A 1298C polymorphisms and homocysteine levels in primary open angle and primary closed angle glaucoma. Mol Vis 2009; 15: 2268-2278.
20. Gotto AM, NCEP ATP III guidelines incorporates global risk assessment. Am J Manag Care 2003; (Suppl): 1, 3.
21. Vilaseca MA, Moyano D, Ferrer I, Artuch R. Total homocysteine in pediatric patients. Clin Chem 1997; 43: 690-691.
22. Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon Genest JJ. Plasma total homocysteine in healthy subjects; sex specifc relation with biological traits. Am J Clin Nutr 1996; 64: 587-593.
23. Thögersen AM, Nilsson TK, Dahlen GJ, Jan-Håkans K, Huhtasaari F, Hallmans G. Homozygocity for the C677→T mutation of 5, 10-methylene tetrahydrofolate reductase and total plasma homocysteine are not associated with greater than normal risk of a first myocardial infarction in Northern Sweden. Coron Artery Dis 2001; 12: 85-90.
24. Pinto X, Vilaseca MA, Garcia - Giralt N, Ferrer I, Pala M, Meco JF, et al. Homocysteine and the methylene tetrahydrafolate reductase C677T allele in premature coronary artery disease. Case control and family studies. Eur J Clin Invest 2001; 31: 24-30.
25. Rama Devi RA, Govindhiah V, Ramakrishna G, Nausad SM. Prevalence of methylene tetrahydrofolate polymorphism in South Indian population. Curr Sci 2004; 86: 440-443.
26. Kennedys BP, Farag NH, Zieglar MG, Mills PJ. Relationship of systolic blood pressure with plasma homocysteine: importance smoking status. J Hypertens 2003, 21: 1307-1312.
27. Hsu LA, Ko YL, Wang SM, Chang CJ, Hsu TS, Chiang CW, et al. The C677T mutation of the methylene tetrahydrofolate reductase gene is not associated with the risk of coronary artery disease or venous thrombosis among Chinese in Taiwan. Hum Hered 2001; 51: 41-45.
28. Robert Y.L. ZEE, Samia Mora, Suzanne Cheng, Henry A Erlich, Klaus Lindpaintner, Nader R, et al. Homocysteine, 5,10-methylene tetrehydrofolate reductase 677 C>T polymorphism, nutrient intake and incident cardiovascular disease in 24968 initially healthy women. Clin Chem 2007; 53: 845-851.
29. Lin PT, Huang MC, Lee BJ, Chang CH, Tsai TP, Huang YC, et al. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylene tetrahydrofolate reductase 677 C→T genes. Asia Pac J Clin Nutr 2008; 17: 330-338.
30. Rossoul F, Richter V, Hertschal B, Geisel J, Hermann W, Kuntze T, et al. Plasma homocysteine levels and 677 C→T methylene tetrahydrofolate reductase gene polymorphism in patients with coronary artery disease of different severity. Indian J Med Res 2008; 127: 154-158.
31. Frederiksen J, Juul K, Grande P, Jensen GB, Schroeder TV, Anne TH, et al. MTHFR polymorphism (C667→ T) hyperhomocystenemia, and risk of ischaemic cardiovascular disease and venous thromboembolism: prospective and case control studies from Copenhagen City Heart Study. Blood 2004; 104: 3028-3037.
32. Anand S, Yusuf S, Vuksan V, Devaneshan S, Teo K, Montagia A, et al. Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada, the study of Health Assessment and Risk in Ethnic Groups (SHARE). Indian Heart J 2000; 5 (Suppl): S35-S43.
33. Malinow MR, Sexton G, Averbuch M, Grossman M, Wilson O, Opson B, et al. Homocysteinemia in daily practice: levels in coronary artery disease. Circulation 1996; 94: 2154-2158.
34. Gallagher PM, Meceady R, Sheilds DC, Tan KS, McMaster D, Rozen R. Homocysteine and risk of premature coronary heart disease. Circulation 1996; 94: 2154-2158.